Last reviewed · How we verify
NCT04856423
Ultra-sensitivity Quantitative Fecal Immunochemical Test in Detecting Colorectal Advanced Adenoma and Colorectal Cancer
trial testing The us-qFIT and colonoscopy with pathological examination in Colorectal Neoplasm in 6,000 participants. Status unknown.
19 April 2023
Quick facts
| Lead sponsor | Shandong University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 6,000 |
| Start date | 19 April 2021 |
| Primary completion | 19 April 2023 |
| Estimated completion | 30 June 2023 |
| Sites | 6 locations across China |
Drugs / interventions tested
- The us-qFIT and colonoscopy with pathological examination
Conditions studied
- Colorectal Neoplasm — all drugs for Colorectal Neoplasm →
Sponsor
Shandong University
Who can join
Adults 50 to 75, any sex, with Colorectal Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Early detecting and removing of colorectal advanced adenomas can reduce the incidence of colorectal cancer. Because of the less bleeding of advanced adenomas, sensitivities of the common used quantitative fecal immunochemical tests (qFITs) are unsatisfying. Ultra-sensitivity qFIT(us-qFIT) can determine extremely low fecal hemoglobin concentration compared with the common used qFIT. This study will prove the diagnostic accuracy of us-qFIT in detecting colorectal advanced adenomas.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04856423
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Neoplasm
Currently open trials in the same condition.
- NCT05953662 — Safety and Efficacy of Reduced-port Laparoscopic Surgery for Patients Of Colon and Upper Rectal Cancer · NA · active not recruiting
- NCT05419011 — Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome · Phase 2 · active not recruiting
- NCT04185779 — COLO-COHORT (Colorectal Cancer Cohort) Study · recruiting
- NCT03936530 — Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer · active not recruiting
- NCT02758951 — Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases · Phase 2, PHASE3 · active not recruiting
Other Shandong University trials
Trials by the same sponsor.
- NCT07288346 — Effect of Predictive Model on Double-Balloon Enteroscopy · NA · recruiting
- NCT07325344 — Active Locomotion of Magnetically Controlled Capsule Endoscopy in the Small Bowel: A Feasibility Study · NA · recruiting
- NCT07319312 — Evaluating the Effect of Nurse-Led Stroke Transitional Care in Tanzania · recruiting
- NCT07391787 — Low-acid Contrast Media for Preventing Post ERCP Pancreatitis · completed
- NCT07066059 — Study on the Efficacy and Safety of Shouhui Tongbian Capsules in Protecting Intestine During the Perioperative Period · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04856423 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shandong University
- Last refreshed: 16 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04856423.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing